Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARI-0001 |
Trade Name | |
Synonyms | ARI0001|ARI 0001|PEI 19-187 |
Drug Descriptions |
ARI-0001 are autologous T-lymphocytes engineered to express a CD137-based chimeric antigen receptor (CAR) targeting CD19, which may have antitumor activity (PMID: 35174095). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C179725 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARI-0001 | ARI-0001 | 0 | 2 |